AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2 1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer
1. 当前求助状态已完结, 请及时下载应助文件
2. 系统将在 2026-01-14 17:19:27 删除文件
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/2159-8290.cd-23-0984
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Olivier Nolan-Stevaux; Cong Li; Lingming Liang; Jinghui Zhan; Juan Estrada; Tao Osgood; Fei Li; Hanzhi Zhang; Ryan Case; Christopher M. Murawsky; Bram Estes; Gregory L. Moore; Matthew J. Bernett; Umesh Muchhal; John R. Desjarlais; Binnaz K. Staley; Jennitte Stevens; Keegan S. Cooke; Famke Aeffner; Oliver Thomas; Julia Stieglmaier; Jae-Lyun Lee; Angela Coxon; Julie M. Bailis
全文下载地址: https://aacrjournals.org/cancerdiscovery/article-pdf/doi/10.1158/2159-8290.CD-23-0984/3373491/cd-23-0984.pdf
